Vitamin D deficiency alters prostate epithelial differentiation and increases prostate cancer aggressiveness in ex vivo and in vivo models

This study demonstrates that biologically relevant vitamin D deficiency impairs prostate epithelial differentiation and enhances cancer aggressiveness by disrupting androgen signaling and key cancer-related pathways in both ex vivo and in vivo models, thereby supporting the potential of vitamin D supplementation to mitigate prostate cancer risk.

The Gist

Imagine your prostate is a bustling construction site where new cells are constantly being built, repaired, and organized. For this site to run smoothly, it needs two main foremen: Androgens (like testosterone) and Vitamin D.

For a long time, we knew the Androgen foreman was essential. But this new study reveals that Vitamin D is actually a super-foreman that does something even more critical: it teaches the new cells how to grow up, become specialized, and behave properly. When Vitamin D is missing, the construction site gets chaotic, and the buildings (cells) become more dangerous and aggressive.

Here is the story of what the researchers found, broken down into simple concepts:

1. The "Gym Class" Experiment (Organoids)

The researchers took tiny samples of prostate tissue from mice and grew them in a lab dish, like a miniature city of cells called an organoid.

• The Test: They gave some cities just Androgens, some just Vitamin D, and some both.
• The Result: The cities with Vitamin D grew much bigger and more organized. The cells learned to differentiate (grow up) into their proper adult forms much better than the ones with just Androgens.
• The Analogy: Think of Androgens as the bricks and mortar. They build the structure. But Vitamin D is the architect and the teacher. Without the teacher, the bricks are there, but the building is messy and unstable. With the teacher, the building is strong and well-organized.

2. The "Starving City" (Vitamin D Deficiency in Mice)

Next, they fed a group of mice a diet with almost no Vitamin D for six months, while another group ate a healthy, Vitamin D-rich diet.

• The Surprise: The mice on the bad diet didn't look sick. Their prostates didn't look weird under a microscope. They seemed fine on the outside.
• The Secret: However, when the researchers looked at the instructions inside the cells (the genes), they found a disaster. The cells in the Vitamin D-deficient mice were confused. They were misreading the "Androgen" instructions.
• The Analogy: Imagine a city that looks normal from the street, but inside the power plant, the workers are speaking a different language. The "Androgen" signals are being shouted, but the cells are hearing them wrong. This confusion makes the cells more likely to turn into troublemakers later on.

3. The "Long-Term Training" (Human Cancer Cells)

Finally, they took human prostate cancer cells (MDA-PCa-2b) and did a very long experiment. They kept some cells in a normal dish, and they kept others in a dish with Vitamin D for six months.

• The Short-Term View: If you give cancer cells Vitamin D for just a day, they might slow down a little, but they are still dangerous.
• The Long-Term View: After six months of living with Vitamin D, the cancer cells changed their personality completely. They became so "well-behaved" that when the researchers tried to inject them into mice to grow tumors, the tumors refused to grow.
• The Analogy: Think of the cancer cells as a rowdy gang.
  • Short-term Vitamin D: Like a police officer showing up for 10 minutes. The gang stops fighting for a moment, but as soon as the officer leaves, they start again.
  • Long-term Vitamin D: Like sending the gang to a strict, positive boarding school for six months. By the time they graduate, they have completely reformed. They no longer want to cause trouble; they've lost the ability to be aggressive.

Why Does This Matter?

This study connects the dots between two big problems:

1. Vitamin D Deficiency: Many people, especially Black men in the US, don't get enough Vitamin D.
2. Aggressive Prostate Cancer: These same groups often get more aggressive forms of prostate cancer.

The researchers found that not having enough Vitamin D doesn't just mean "weak bones." It actually changes the "software" of the prostate cells, making them more likely to become aggressive cancer. It's like leaving the security system of a house turned off; eventually, the bad guys (cancer) find it easier to break in and take over.

The Bottom Line

Vitamin D isn't just a vitamin; it's a hormone that acts as a strict teacher for your prostate cells.

• With enough Vitamin D: Cells grow up, stay organized, and behave.
• Without enough Vitamin D: Cells get confused, ignore safety rules, and become more dangerous.

This suggests that keeping Vitamin D levels healthy might be a simple, powerful way to lower the risk of aggressive prostate cancer, acting as a preventative shield before the disease even starts.

Technical Summary

1. Problem Statement

Prostate cancer (PCa) remains a leading cause of cancer-related mortality in men, with significant racial disparities; non-Hispanic Black men face higher risks of diagnosis and mortality. Vitamin D deficiency is highly prevalent, particularly in these high-risk populations, and has been epidemiologically linked to aggressive PCa. However, the specific biological mechanisms by which vitamin D deficiency alters prostate epithelial differentiation and androgen signaling in a biologically relevant context remain poorly defined. Most existing studies rely on short-term in vitro treatments or genetically engineered mouse models, which may not capture the chronic, systemic effects of dietary deficiency on normal prostate biology and tumor initiation.

2. Methodology

The study employed a multi-modal approach using ex vivo organoid cultures, in vivo dietary mouse models, and human prostate cancer cell line adaptation to investigate the long-term effects of vitamin D status.

• Ex Vivo Mouse Prostate Organoids:

  • Primary cells from C57BL/6 mouse prostate lobes (specifically dorsolateral lobes) were cultured into 3D organoids.
  • Organoids were treated with vehicle, Dihydrotestosterone (DHT), 1,25-dihydroxyvitamin D (1,25D), or a combination.
  • Analysis: Phenotypic imaging (size, morphology), passaging assays (regeneration capacity), and Single-Cell RNA Sequencing (scRNA-seq) to profile epithelial differentiation and gene expression changes.

• In Vivo Dietary Deficiency Model:

  • Wild-type male C57BL/6 mice were fed either a Vitamin D-sufficient control diet (2.2 IU/g) or a Vitamin D-deficient diet (0.05 IU/g) for 24 weeks.
  • Analysis: Serum 25-hydroxyvitamin D (25D) levels were quantified via LC-MS/MS. Prostate tissues underwent histology (H&E) and scRNA-seq to identify cell-type-specific transcriptional changes in the absence of gross pathology.

• Human Prostate Cancer Cell Line Adaptation (MDA-PCa-2b):

  • MDA-PCa-2b cells (androgen-sensitive, derived from an African American male) were maintained for six months in media containing vehicle, 1 nM 1,25D, or 10 nM 1,25D to simulate chronic hormonal exposure.
  • Xenograft Assay: Adapted cells were injected into castrated SCID mice with testosterone implants to assess tumorigenicity.
  • Molecular Profiling: Bulk RNA-seq, Western Blotting, and qPCR were performed to compare acute (24h) vs. chronic (6-month) treatment effects on gene expression, protein levels (VDR, AR, FKBP5), and pathway activation.

3. Key Contributions

• Differentiation Hierarchy: Demonstrated that Vitamin D promotes luminal epithelial differentiation in prostate organoids more potently than androgens alone.
• Chronic vs. Acute Signaling: Established a critical distinction between short-term (pulse) vitamin D treatment and long-term (chronic) adaptation, revealing that chronic exposure induces a unique transcriptional reprogramming distinct from acute responses.
• Deficiency Mechanism: Identified that systemic vitamin D deficiency reprograms androgen-responsive genes in normal prostate luminal cells, creating a molecular environment permissive for aggressive disease even before tumor formation.
• Loss of Tumorigenicity: Showed that chronic vitamin D exposure renders human prostate cancer cells incapable of forming xenografts, despite maintaining in vitro proliferation.

4. Key Results

A. Vitamin D Enhances Differentiation (Organoid Models)

• Morphology: Organoids treated with 1,25D (alone or with DHT) were significantly larger and exhibited more luminal differentiation than those treated with DHT alone.
• Regeneration: 1,25D-treated organoids retained superior regenerative capacity upon dissociation and reseeding.
• scRNA-seq Findings:
  • 1,25D treatment increased the proportion of luminal cells and upregulated Tacstd2 (Trop2), a marker of progenitor cells essential for organoid regeneration.
  • Gene Set Enrichment Analysis (GSEA) revealed that 1,25D uniquely activated pathways related to metabolism, inflammatory signaling, and late estrogen response, distinct from androgen-only effects.

B. Vitamin D Deficiency Alters Androgen Signaling (In Vivo)

• Phenotype: Mice on the deficient diet had undetectable serum 25D levels but showed no gross histological abnormalities or weight loss.
• Transcriptional Reprogramming: scRNA-seq of prostate luminal cells from deficient mice revealed significant dysregulation of androgen-responsive genes compared to controls.
  • Upregulated: Fkbp5, Bmpr1b, Sdf2l1, Creld2, B2m, Abhd2.
  • Downregulated: Yeats2, Tmprss2.
• Implication: Vitamin D deficiency creates a transcriptional state in normal luminal cells that mimics altered androgen signaling, potentially priming the tissue for malignancy.

C. Chronic Vitamin D Exposure Suppresses Aggressiveness (Human Cell Lines)

• Xenograft Failure: MDA-PCa-2b cells adapted to 1 nM or 10 nM 1,25D for 6 months failed to form tumors in SCID mice, whereas vehicle-treated controls formed palpable, PSA-producing tumors.
• Transcriptional Divergence:
  • There was minimal overlap (<12%) between genes differentially expressed in acute (24h) vs. chronic (6-month) 1,25D treatments.
  • Acute Treatment: Preserved canonical androgen signaling (upregulation of KLK3/PSA, FKBP5, AR targets).
  • Chronic Adaptation: Induced a distinct program. Low-dose (1nM) adaptation enriched transcriptional regulators (GATA2, NDRG1), while high-dose (10nM) enriched extracellular matrix and cytoskeleton genes (FN1, IQGAP2).
  • Pathway Shift: The canonical VDR-RXR activation pathway was enriched only in acute treatment; it was absent in 6-month adapted cells, indicating a fundamental shift in cellular state.
• Protein Levels: Chronic treatment led to reduced FKBP5 protein and attenuated KLK3 expression, despite normal AR protein levels, suggesting a decoupling of androgen receptor signaling from its downstream effectors.

5. Significance

• Mechanistic Insight: This study provides the first evidence that vitamin D deficiency acts as a driver of prostate cancer aggressiveness by altering the differentiation trajectory and androgen responsiveness of normal prostate epithelium before tumor initiation.
• Racial Disparities: The findings offer a mechanistic explanation for the higher incidence of aggressive PCa in non-Hispanic Black men, a group with high rates of vitamin D deficiency.
• Therapeutic Implications: The data suggest that maintaining biologically relevant levels of vitamin D is crucial for prostate homeostasis. It highlights that short-term supplementation trials may fail to capture the benefits of sustained hormonal balance.
• Model Validation: The study validates the use of chronic adaptation models over acute pulse treatments to better mimic the physiological reality of hormone exposure in cancer biology.

In conclusion, the paper establishes vitamin D as a critical hormonal regulator of prostate epithelial differentiation and androgen signaling. Deficiency creates a permissive molecular landscape for aggressive disease, while chronic sufficiency promotes differentiation and suppresses tumorigenic potential.